Precision Medicine World Conference
Duke University 2018

Meet with Q2 Solutions at PMWC Duke University

Duke University, Durham, NC | September 24, 2018 - September 25, 2018 | 09:00 - 18:00 Add to Calendar
Stay Informed Schedule a Meeting

About This Event

The Precision Medicine World Conference (PMWC) 2018 Duke, the 15th installment of the conference, will spotlight the latest advancements within biomedical technologies, driving initiatives that enable the translation of precision medicine into direct improvements in health care.

With laboratory services that span the development lifecycle and industry-leading scientists with extensive drug development experience, Q² Solutions can help you accelerate your path to precision medicine.

Plan to join our Ph.D., Principal Bioinformaticist and Scientific Advisor, Wendell Jones, on September 25th, at PMWC - Duke University in his session, “Immune Landscape Signatures: Characterization of Tumor Microenvironment (TME) and Response to Therapy”, where he will discuss the detection of Immune Landscape Signatures for characterization of tumor microenvironment and response to therapy.

Learn more about our precision medicine, companion diagnostics and genomics services, and register to attend on the event website.

We look forward to meeting you in Durham.

Related Services:

Register for Event


Wendell Jones, Ph.D.

Dr. Wendell Jones is Principal Bioinformaticist and Scientific Advisor at Q2 Solutions | EA Genomics. He conducts collaborative scientific research in multiple areas, including immuno-oncology and autoimmune disorders. His background includes analysis, development and validation of the bioinformatic systems that process complex genomic assays, including next generation sequencing assays, evaluating new and emerging genomic technologies, and developing bioinformatic and biomarker implementation strategies. He consults with clients and provides thought leadership in industry and public consortiums, including the MAQC/SEQC consortiums, involved in genomic science and measurement.  

Dr. Jones received his BS in mathematics at Furman University and his MS and PhD in math sciences (emphasis in statistics) at Clemson University.  He has over 17 years of experience in advanced genomic technologies and biomarker development and 22 years of experience in scientific and technology leadership positions.   In addition to his duties at Q2 Solutions | EA Genomics, Dr. Jones is currently President and founding member of the Board of Directors of the Massive Analysis and Quality Control Society (MAQC Society), a relatively new society devoted to enhancing reproducibility in scientific methods, especially in “Big Data” areas such as genomic science.    He is author or co-author of over 50 peer-reviewed publications in genomics and engineering.

Precision medicine: Shifting from one drug for all patients to personalized genomics-based therapeutic options

Read More